[1]
Keen, R., Pantin, J., Savage, N. and Dainer, P.M. 2016. Treatment of refractory anemia with ring sideroblasts associated with marked thrombocytosis with lenalidomide in a patient testing negative for 5q deletion and JAK2 V617F and MPL W515K/L mutations. Hematology Reports. 8, 4 (Nov. 2016). DOI:https://doi.org/10.4081/hr.2016.6592.